RPg Family Wealth Advisory’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,711
| Closed | -$599K | – | 120 |
|
|
2023
Q1 | $599K | Sell |
7,711
-3,481
| -31% | -$270K | 0.33% | 55 |
|
|
2022
Q4 | $870K | Buy |
11,192
+176
| +2% | +$13.7K | 0.6% | 48 |
|
|
2022
Q3 | $779K | Hold |
11,016
| – | – | 0.41% | 57 |
|
|
2022
Q2 | $846K | Buy |
11,016
+3,731
| +51% | +$287K | 0.5% | 47 |
|
|
2022
Q1 | $581K | Buy |
7,285
+113
| +2% | +$9.01K | 0.25% | 66 |
|
|
2021
Q4 | $552K | Buy |
7,172
+327
| +5% | +$25.2K | 0.22% | 66 |
|
|
2021
Q3 | $498K | Buy |
6,845
+198
| +3% | +$14.4K | 0.21% | 80 |
|
|
2021
Q2 | $486K | Buy |
+6,647
| New | +$486K | 0.2% | 84 |
|
|
2020
Q4 | $212K | Buy |
+3,184
| New | +$212K | 0.1% | 113 |
|